Search

A new book from an MIT Sloan School of Management professor explores how we balance doing what’s right with doing what works — and what we’re really willing to give up for our values.

Companies that adopt industrial artificial intelligence see productivity losses before longer-term gains, according to new research.

Researchers propose new royalty-based investment model to bridge the ‘valley of death’ and accelerate drug development.

Artificial intelligence improves efficiency in risk management and compliance, but humans are still best for customer-facing tasks, a new study finds.

Enterprises racing to adopt AI must be wary of giving into hype, downplaying ethical concerns, and focusing on use cases that won’t generate real value.

The startup’s device could expand access, reduce cost, and reduce injection time for biologic drugs for cancer and autoimmune diseases.

From assessing bridge infrastructure to predicting worker fatigue risk via voice analysis, these startups are widening the scope of what artificial intelligence can do.

And why. Plus, an inclusive innovation scorecard.

Universities can seed regional economic growth by attracting and training top talent who go on to file patents and found local companies, a new study shows.

MIT Sloan climate expert John Sterman spells out the actions businesses can take to mitigate the economic and ecological harms of global warming.